Skip to main content
Log in

Structural analysis ofBacillus licheniformis 86 surfactant

  • Original Papers
  • Published:
Journal of Industrial Microbiology

Summary

A tentative structure and composition of a surfactant, BL-86, produced byBacillus licheniformis 86 is described. The surfactant is a mixture of lipopeptides with the major components ranging in size from 979 to 1091 Da and varying in increments of 14 Da. The variation in molecular weight represents changes in the number of methylene groups in the lipid and/or peptide portion of the surfactant. There are 7 amino acids per molecule. The peptide portion is composed of the following amino acids: glutamic acid or glutamine (glx), aspartic acid or asparagine (asx), valine, leucine, and isoleucine at a ratio of 1.0∶1.0∶1.4∶3.0∶0.6, respectively. The leucine is present as both thed andl isomers at a ratio of about 2∶1, respectively. Forty percent of the molecules containl-valine instead ofl-isoleucine. The glx and asx are present as a combination ofl-glutamic acid andl-asparagine and/orl-glutamine andl-aspartic acid. The N-terminus of the peptide is blocked, most likely by a peptide bond to the lipid portion. An ester carbonyl structure is present, which could be a part of a lactone ring connecting the β position of the lipid to one of the carboxyl groups in the peptide. The lipid portion is composed of, on average, 8–9 methylene groups, and contains a mixture of linear and branched tails. Results of DCI-MS and FAB-MS analyses, as well as surface tension measurements, of purified BL-86 HPLC fractions support the proposed composition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Arima, K., A. Kakinuma, and G. Tamura. 1968. Surfactin, a crystalline peptidelipid surfactant produced byBacillus subtilis: Isolation, characterization and its inhibition of fibrin clot formation. Biochem. Biophys. Res. Commun. 31: 488–494.

    Google Scholar 

  2. Arima, K., G. Tamura, and A. Kakinuma. 1972. Surfactin. United States Patent No. 3,687,926.

  3. Bernheimer, A.W., and L.S. Avigad. 1970. Nature and properties of a cytological agent produced byBacillus subtilis. J. Gen. Microbiol. 61: 361–369.

    Google Scholar 

  4. Cooper, D.G., C.R. MacDonald, S.J.B. Duff, and N. Kosaric. 1981. Enhanced production of surfactin fromBacillus subtilis by continuous product removal and metal cation additions. Appl. Environ. Microbiol. 42: 408–412.

    Google Scholar 

  5. Horowitz, S., J.N. Gilbert, and W.M. Griffin. 1990. Isolation and characterization of a surfactant produced byBacillus licheniformis 86. J. Ind. Microbiol., In Press.

  6. Hosono, K. and H. Suzuki. 1983. Acylpeptides, the inhibitors of cyclic adenosine 3′,5′-monophosphate phosphodiesterase I. Purification, physicochemical properties and structures of fatty acid residues. J. Antibiot. 36: 667–673.

    Google Scholar 

  7. Hosono, K. and H. Suzuki. 1983. Acylpeptides, the inhibitors of cyclic adenosine 3′,5′-monophosphate phosphodiesterase II. Amino acid sequence and location of lactone linkage. J. Antibiot. 36, 674–678.

    Google Scholar 

  8. Javaheri, M., G.E. Jenneman, M.J. McInerney, and R.M. Knapp. 1985. Anaerobic production of a biosurfactant byBacillus licheniformis JF-2. Appl. Environ. Microbiol. 50: 698–700.

    Google Scholar 

  9. Jenneman, G.E., M.J. McInerney, R.M. Knapp, J.B. Clark, J.M. Feero, D.E. Revus, and D.E. Menzie. 1983. A halotolerant, biosurfactant-producingBacillus species potentially useful for enhanced oil recovery. Dev. Ind. Microbiol. 24: 485–492.

    Google Scholar 

  10. Kakinuma, A., M. Hori, H. Sugino, I. Yoshida, M. Isono, G. Tamura, and K. Arima. 1969. Determination of the location of lactone ring in surfactin. Agr. Biol. Chem. 33: 1523–1524.

    Google Scholar 

  11. Kakinuma, A., M. Hori, M. Isono, G. Tamura, and K. Arima. 1969. Determination of amino acid sequence in surfactin, a crystalline peptide lipid surfactant produced byBacillus subtilis. Agr. Biol. Chem. 33: 971–972.

    Google Scholar 

  12. Kakinuma, A., H. Sugino, M. Isono, G. Tamura, and K. Arima. 1969. Determination of fatty acid in surfactin and elucidation of the total structure of surfactin. Agr. Biol. Chem. 33: 973–976.

    Google Scholar 

  13. Kluge, B., J. Vater, J. Salnikow, and K. Echart. 1988. Studies on the biosynthesis of surfactin, a lipopeptide antibiotic fromBacillus subtilis ATCC 21332. FEBS Lett. 231: 107–110.

    Google Scholar 

  14. Marfey, P. 1984. Determination of D-amino acids. II. Use of a reagent, 1,5-difluoro-2,4-dinitrobenzene. Carlsberg Res. Commun. 49: 591–596.

    Google Scholar 

  15. McInerney, M.J., G.E. Jenneman, R.M. Knapp, and D.E. Menzie. 1985. Biosurfactant and enhanced oil recovery. U.S. Patent No. 4,522,261.

  16. Nakano, M.M., M.A. Marahiel, and P. Zuber. 1988. Identification of a genetic locus required for biosynthesis of the lipopeptide antibiotic surfactin inBacillus subtilis. J. Bacteriol. 170: 5662–5668.

    Google Scholar 

  17. Stahl, E. 1969. Thin Layer Chromatography, p. 745. Springer-Verlag (2nd).

  18. Thomas, D.W., and T. Ito. 1969. The revised structure of the peptide antibiotic esperin, established by mass spectrometry. Tetrahedron 25: 1985–1990.

    Google Scholar 

  19. Vater, J. 1986. Lipopeptides, an attractive class of microbial surfactants. Prog. Colloid Polymer Sci. 72: 12–18.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Horowitz, S., Griffin, W.M. Structural analysis ofBacillus licheniformis 86 surfactant. Journal of Industrial Microbiology 7, 45–52 (1991). https://doi.org/10.1007/BF01575602

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01575602

Key words

Navigation